Skip to main content

Table 6 PCDH10 methylation status according to clinicopathological features of patients (n = 23)

From: High methylation levels of PCDH10 predict poor prognosis in patients with pancreatic ductal adenocarcinoma

Variable

PCDH10

Low:

High:

P°

n (%)

n (%)

Gender

 Male

7 (43.8)

4 (57.1)

0.554

 Female

9 (56.3)

3 (42.9)

Jaundice

 No

4 (25.0)

5 (71.4)

0.036*

 Yes

12 (75.0)

2 (28.6)

Vascular invasion

 No

15 (93.8)

7 (100.0)

0.499

 Yes

1 (6.3)

0 (0.0)

Neural invasion

 No

13 (81.3)

5 (71.4)

0.621

 Yes

3 (18.8)

2 (28.6)

LN metastasis

 No

4 (25.0)

2 (28.6)

1.000

 Yes

12 (75.0)

5 (71.4)

Stage

 II

4 (28.6)

2 (28.6)

1.000

 III

10 (71.4)

5 (71.4)

  1. °Pearson’s χ2 test
  2. *Statistically significant